Don't give up yet on biosimilars, Gottlieb says. Congress could give them a boost

26th August 2019 Uncategorised 0

While some drug pricing experts believe biosimilars won’t deliver meaningful savings in the U.S.—and that it’s time to throw in the towel—Scott Gottlieb says it’s too early to accept defeat. Congress could do a few things to boost the budding copycat field, the former FDA chief figures.

More: Don't give up yet on biosimilars, Gottlieb says. Congress could give them a boost
Source: fierce